Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts.
about
Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.Concordance of bioactive vs. total immunoreactive serum leptin levels in children with severe early onset obesityHigh levels of cathepsin D and cystatin B are associated with increased risk of coronary events.Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.Circulating ApoJ is closely associated with insulin resistance in human subjects.Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy.Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes.
P2860
Q33570959-670254C9-BD95-4FB5-B325-7EAFF53D7525Q33718974-9CB50488-EE50-49E5-A904-877085BDCDEDQ36517244-3BB74590-F774-4B0D-B16D-986306DF276BQ36872752-03F00FA3-CA3B-46BE-A01B-97935B7587F3Q38636706-6C4B07BC-7189-436D-9784-EF65DB266010Q38737288-D26F1526-42EB-414B-B6F9-2C40958771E8Q46520402-EAE06751-EF7D-4984-BDF6-149F146886CCQ47108521-64D69A20-6C1B-4404-9491-781CFFBD341FQ48156043-F5E32DF1-6320-46FF-9D93-149D09128D4E
P2860
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Protein Biomarkers for Insulin ...... n Two Large Community Cohorts.
@en
type
label
Protein Biomarkers for Insulin ...... n Two Large Community Cohorts.
@en
prefLabel
Protein Biomarkers for Insulin ...... n Two Large Community Cohorts.
@en
P2860
P50
P356
P1433
P1476
Protein Biomarkers for Insulin ...... n Two Large Community Cohorts.
@en
P2093
Vilmantas Giedraitis
P2860
P304
P356
10.2337/DB15-0881
P407
P577
2015-09-29T00:00:00Z